Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction–associated steatotic liver disease - Poll - MDSpire

Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction–associated steatotic liver disease

  • By

  • Rishi Chowdhary

  • Manjeet Kumar Goyal

  • Megh Patel

  • Rahul Chowdhary

  • Kirti Arora

  • Varun Mehta

  • Akash Batta

  • Omesh Goyal

  • Ashita Rukmini Vuthaluru

  • June 11, 2026

  • 0 min

Share

Original Source(s)

Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction–associated steatotic liver disease

  • by Rishi Chowdhary, Manjeet Kumar Goyal, Megh Patel, Rahul Chowdhary, Kirti Arora, Varun Mehta, Akash Batta, Omesh Goyal, Ashita Rukmini Vuthaluru

  • June 11, 2026

Related Content

Preoperative electrolyte-based metabolic biomarkers for prognostic assessment in gastric cancer: a multicenter study

Clinical and genetic characteristics of children with sodium taurocholate cotransporting poly-peptide deficiency

Erxiekang emplastra as adjunctive therapy for acute gastroenteritis in children: a single-center retrospective cohort study